Mirae Asset Global Etfs Holdings Ltd. Nuvalent, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 24,862 shares of NUVL stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,862Holding current value
$2.35 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVL
# of Institutions
179Shares Held
56.6MCall Options Held
527KPut Options Held
131K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$1.89 Billion31.83% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.57MShares$432 Million14.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.78MShares$356 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$285 Million0.01% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.7MShares$255 Million41.86% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $4.06B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...